Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour are crucial to understanding

To read the full story...

Already a subscriber? Login now

< | >